Leuthold Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,824
Closed -$487K 206
2023
Q2
$487K Hold
4,824
0.06% 153
2023
Q1
$444K Sell
4,824
-276
-5% -$24.1K 0.06% 150
2022
Q4
$463K Sell
5,100
-87
-2% -$7.33K 0.06% 150
2022
Q3
$394K Hold
5,187
0.06% 147
2022
Q2
$438K Buy
+5,187
New +$455K 0.06% 143
2020
Q4
Sell
-5,554
Closed -$483K 188
2020
Q3
$483K Sell
5,554
-154
-3% -$13.3K 0.07% 126
2020
Q2
$499K Sell
5,708
-224
-4% -$19.3K 0.07% 113
2020
Q1
$489K Sell
5,932
-551
-8% -$49.2K 0.09% 115
2019
Q4
$614K Buy
+6,483
New +$582K 0.08% 115

Other funds holding NVS

Leuthold Group's NVS Position: Q3 2023 in Review

Leuthold Group sold out of Novartis (NVS) in Q3 2023, closing a stake of 4,824 shares — an estimated $487K sold.

Leuthold Group first reported a position in NVS in Q4 2019 and held it in 9 quarters. The position peaked at $614K in Q4 2019. 1,223 funds tracked by Wall St. Rank hold NVS as of Q3 2023.

  • Leuthold Group reported no remaining Novartis position as of Q3 2023 after selling out during the quarter.
  • Leuthold Group sold 4,824 Novartis shares in Q3 2023, an estimated $487K.
  • Leuthold Group first reported a position in Novartis in Q4 2019 and held it in 9 quarters.
  • Leuthold Group's Novartis position peaked at $614K in Q4 2019.
  • 1,223 funds tracked by Wall St. Rank held Novartis as of Q3 2023.

Based on Leuthold Group's 13F filing for Q3 2023, filed 7 Nov 2023.